Insmed Ranks No. 1 on Science’s 2023 Top Biopharma Employers List
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it has earned the highest ranking in Science‘s 2023 Top Employers Survey. The annual survey polls employees…
Ketul J. Patel named to Modern Healthcare’s Top Diversity Leaders List
Virginia Mason Franciscan Health (VMFH) is proud to announce that Ketul J. Patel, CEO of VMFH and Division President, Pacific Northwest CommonSpirit was recognized by Modern Healthcare as one of 2023’s Top Diversity Leaders. The program honors the top diverse healthcare executives…
New York Festivals 2024 Health Awards Open for Entries
The New York Festivals 2024 NYF Health Awards, celebrating excellence in Healthcare, Wellness and Pharmaceutical advertising, is now open for entries. For 2024, New York Festivals Health Awards will once again hold live, face-to-face Executive Jury sessions in New York City with two separate Executive Juries…
One Health Direct’s Company Culture Committee Promotes Collaboration Between Offices in Florida, Puerto Rico, and The Philippines
One Health Direct’s Company Culture Committee (CCC) has taken an innovative approach to team building by adopting unique initiatives that unite offices separated by time zones and international borders. The committee was established in an effort to lessen the silo…
BulletinHealthcare Launches Healthcare Daily News
BulletinHealthcare announced today that it has launched Healthcare Daily News, a daily email briefing designed broadly for healthcare providers, including physicians, nurses, physician assistants, and pharmacists. Healthcare Daily News – distributed every weekday by 8 a.m. ET – is one of BulletinHealthcare’s independently-published briefing. The…
Triumvira Immunologics Announces First Patient Dosed in Phase II of TACTIC-2 Cell Therapy Trial for the Treatment of HER2+ Gastric and GEJ Cancers
Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced that the first patient has been dosed in Phase II…
RoadMap Technologies Expands Privacy Solutions to Support JSON Based De-Identification, FDA Clinical Trials, and Healthcare Claims
RoadMap Technologies, a leading provider of data science and software solutions for the Life Sciences industry, today announced that RoadMap has expanded its HITRUST certified platform to support JSON-based De-identification, as well as FDA Clinical Trials and Healthcare Claims data…
Biolexis Therapeutics launches subsidiary Metabolexis to develop novel oral medicines for Obesity and Type 2 Diabetes to improve human longevity
Biolexis Therapeutics, a clinical-stage AI-enabled drug discovery company, today announced the launch of Metabolexis, a new pipeline company developing three targeted oral small molecules for the treatment of Obesity and Type 2 Diabetes, with the potential to improve human Longevity….
Trio Health Appoints Dr. Mia Nease as Chief Commercial Officer
Trio Health (Trio), a leading clinical data solution provider, has announced the appointment of Mia Nease as its Chief Commercial Officer (CCO). In this role, Nease will lead the advancement of Trio’s commercialization strategy and oversee the development of innovative solutions to…
NRx Pharmaceuticals Announces Further Alignment with FDA on Initiation of Registrational Trials for NRX-101 in the Treatment of Chronic Pain
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company today announced further alignment with the FDA Division of Anesthesiology, Addiction Medicine, and Pain Medicine in connection with the development of NRX-101 for treatment of Chronic Pain. The…
